Patents by Inventor Lenore Pereira

Lenore Pereira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for prenatal diagnosis of congenital cytomegalovirus
    Patent number: 9261505
    Abstract: The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV-infected mothers and fetuses compared to uninfected individuals.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: February 16, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Lenore Pereira, Ekaterina Maidji, Takako Tabata, Susan Jane McDonagh
  • BIOMARKERS FOR PRENATAL DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS
    Publication number: 20140141406
    Abstract: The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV-infected mothers and fetuses compared to uninfected individuals.
    Type: Application
    Filed: October 25, 2013
    Publication date: May 22, 2014
    Inventors: Lenore PEREIRA, Eskaterina Maidji, Takako Tabata, Susan Jane MCDONAGH
  • Biomarkers for prenatal diagnosis of congenital cytomegalovirus
    Patent number: 8609347
    Abstract: The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV-infected mothers and fetuses compared to uninfected individuals.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: December 17, 2013
    Assignee: The Regents of the University of California
    Inventors: Lenore Pereira, Ekaterina Maidji, Takako Tabata, Susan Jane McDonagh
  • BIOMARKERS FOR PRENATAL DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS
    Publication number: 20100304383
    Abstract: The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV-infected mothers and fetuses compared to uninfected individuals.
    Type: Application
    Filed: October 22, 2008
    Publication date: December 2, 2010
    Applicant: The Regents of the University of California
    Inventors: Lenore Pereira, Ekaterina Maidji, Takako Tabata, Susan Jane McDonagh
  • Vaccine for cytomegalovirus
    Patent number: 4689225
    Abstract: A novel subunit vaccine employing glycoprotein A of human cytomegalovirus or fragments thereof is provided. The vaccine is particularly suitable for inoculation of immunosuppressed individuals and women of childbearing age to inhibit the transmission of hCMV to the fetus.
    Type: Grant
    Filed: November 2, 1984
    Date of Patent: August 25, 1987
    Assignee: Institut Merieux
    Inventor: Lenore Pereira